CatalystPit

CBIOCRESCENT BIOPHARMA, INC.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $14.59 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$541.93M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-18 · Brumm Joshua T (Chief Executive Officer) · SELL
  • 2026-09-18 · McNeill Jonathan (President and COO) · SELL
  • 2026-09-18 · Bispham Barbara Harlin (See Remarks) · SELL
  • 2026-09-18 · Lynch Ryan (See Remarks) · SELL
  • 2026-09-18 · Pinkas Jan (Chief Scientific Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders82
Shares held29,703,824
Value$526.09M
Percent of shares outstanding79.97%
As of quarter end2026-06-30
RECENT NEWS
  • CBIO: Crescent Biopharma Announces Grants of Inducement Awards
  • Crescent Biopharma wins FDA approval
  • CBIO: Crescent Biopharma Announces Grants of Inducement Awards
  • The Nascent Crescent Biopharma Thesis: One Year Later And Things Are Steady
  • Crescent Biopharma presents at Morgan Stanley 24th Annual Global Healthcare Conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
CRESCENT BIOPHARMA, INC. (CBIO) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit